Anders Hedlund

Chief Executive Officer at PERPETUA MEDICAL AB

Finance

Consumer Services

Electronic Technology

Profile

Anders Hedlund is the founder of Nolsterby Invest AB, established in 2021, where the title held is Chief Executive Officer.
The current job is Chief Executive Officer & Director at Perpetua Medical AB, starting in 2024.
Former job includes Equity Analyst at Redeye AB from 2017 to 2021.
Education includes a graduate degree from the University of Uppsala, conferred in 2010.

Anders Hedlund active positions

Companies	Position	Start
PERPETUA MEDICAL AB	Chief Executive Officer	01/05/2024
Nolsterby Invest AB Nolsterby Invest AB Investment ManagersFinance Nolsterby Invest invests in companies located in Sweden. The firm focuses on medtech, diagnostics, biotech, life science tools & supplies, and healthtech. It participates in growth stage capital requirements.	Chief Executive Officer	01/08/2021

All active positions of Anders Hedlund

Former positions of Anders Hedlund

Companies	Position	End
Redeye AB Redeye AB Investment ManagersFinance Provides investment research	Analyst-Equity	01/08/2021

See the detail of Anders Hedlund's experience

Training of Anders Hedlund

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anders Hedlund's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Redeye AB Redeye AB Investment ManagersFinance Provides investment research	Finance
Perpetua Medical AB Perpetua Medical AB Electronic Equipment/InstrumentsElectronic Technology Manufactures pharmacological measurements systems	Electronic Technology
Nolsterby Invest AB Nolsterby Invest AB Investment ManagersFinance Nolsterby Invest invests in companies located in Sweden. The firm focuses on medtech, diagnostics, biotech, life science tools & supplies, and healthtech. It participates in growth stage capital requirements.	Finance